title: [ANCA-positive vasculitis of the skin and kidneys associated with acne conglobata].
abstract: A 19 year old man with severe acne conglobata and ulcerated pyoderma gangraenosum-like skin lesions on the face was first treated with isotretinoin (Roaccutan((R))), then immunosuppressively with prednisolone, diaminodiphenylsulfone (Dapson-Fatol((R))) and mycophenolate mofetil (Cellcept((R))). Under a daily maintenance dose of immunosuppressive treatment with 2.5 mg prednisolone and 1 g mycophenolate mofetil, weakness, muscle and joint aches appeared. Due to proteinuria, haematuria and an elevated antineutrophil cytoplasmic antibody (cANCA) and the histological detection of a leukocytoclastic vasculitis, the diagnosis of cANCA positive vasculitis of the skin and kidneys was established. Therapy with cyclophosphamide (Endoxan((R))) along with prednisolone was effective. An exact classification of this disease process was not possible.
authors.affiliation: Klinik und Poliklinik für Hautkrankheiten der Universität Leipzig, Germany. BernMa@gmx.de
authors.forename: B
authors.initials: B
authors.lastname: Manz
authors.forename: M
authors.initials: M
authors.lastname: Rytter
authors.forename: M
authors.initials: M
authors.lastname: Mittag
authors.forename: W
authors.initials: W
authors.lastname: Seidel
authors.forename: P
authors.initials: P
authors.lastname: Nenoff
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D000328:Adult; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000276:immunology*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D004730:Endothelium, Vascular / Q000276:immunology / Q000473:pathology; D005148:Facial Dermatoses / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D015474:Isotretinoin / Q000009:adverse effects / Q000627:therapeutic use; D007668:Kidney / Q000098:blood supply*; D008297:Male; D009504:Neutrophils / Q000276:immunology / Q000473:pathology; D011239:Prednisolone / Q000627:therapeutic use; D017511:Pyoderma Gangrenosum / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D014657:Vasculitis / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology
chemical_list: D019268:Antibodies, Antineutrophil Cytoplasmic; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide; D011239:Prednisolone; D015474:Isotretinoin